Harmony Biosciences Holdings, Inc. Common Stock (HRMY) Stock
NASDAQ · HRMY
42.10
Fundamentals
Market cap
$2.45B
Price / Earnings ratio
13.5x
Price / Sales ratio
2.5x
Price / Book ratio
2.5x
Return on assets
0.1%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Harmony Biosciences Holdings, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees293
CEODr. Jeffrey M. Dayno M.D.
IPO DateAug 19, 2020
HeadquartersPlymouth Meeting, PA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Jeffrey S. Aronin | Founder & Non-Executive Chairman | 1968 |
| Dr. Jeffrey M. Dayno M.D. | President, CEO & Director | 1957 |
| Mr. Peter Anastasiou | Chief Operating Officer | 1970 |
| Dr. Kumar Budur M.D., M.S. | Executive VP and Chief Medical & Scientific Officer | 1971 |
| Mr. Andrew Serafin J.D., M.B.A. | Executive VP & Chief Strategy Officer | 1975 |
| Mr. Adam Zaeske | Executive VP & Chief Commercial Officer | 1973 |
| Mr. Stephen Mollichella | Senior VP, Controller & Interim Principal Financial Officer | — |
| Brennan Doyle | VP & Head of Investor Relations | — |
| Mr. Christian Ulrich J.D. | Executive VP, General Counsel & Corporate Secretary | — |
| Ms. Tricia Glover | Chief Compliance Officer | — |
Fundamentals
Valuation
Market cap$2.45B
Price-to-sales ratio2.55
Price-to-book value2.45
Price-earnings ratio13.50
Return on Equity17.00%
Return on Sales0.24%
Return on Assets0.12%
PEG ratioN/A
Earnings Per Share
Earnings Per Share$3.14
Income Statement
Average volume1,027,557
EBITDA$236.96M
1 year high (52w)$43.49
1 year low (52w)$25.52
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



